Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR12A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,156
Award facts
- Contract value 100% obligated
- $39,155.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards $39,155.90 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Zepbound 5 mg/0.5 mL pens. The Defense Logistics Agency issued this firm fixed-price, non-set-aside contract on January 21, 2026, with an ultimate completion date of January 22, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply contract for military healthcare systems worldwide.
AmerisourceBergen's role as a pharmaceutical distributor positions it to supply critical medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The award of Zepbound, a GLP-1 receptor agonist used for weight management, reflects the federal government's procurement needs for specialty medications. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to fulfill competitive federal medical supply contracts through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices across the DLA's supply chain.
Quick answers
Who was awarded contract SPE2DR26FR12A?
SPE2DR26FR12A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FR12A worth?
The government has obligated $39,156 on SPE2DR26FR12A.
Is contract SPE2DR26FR12A an order under another contract?
Yes. SPE2DR26FR12A is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR12A competed?
The extent of competition for SPE2DR26FR12A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award